ZSP1601
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ZSP1601, covering 2021-10-11 to 2025-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) [Phase 2]